Well Pharmaceutical: Shuntai Zonghua plans to reduce its holdings by no more than 1% of shares
I'm PortAI, I can summarize articles.
Well Pharmaceutical announced that Shuntai Zonghua plans to reduce its holdings by no more than 1.3544 million shares through centralized bidding transactions between August 20 and November 17, 2025, accounting for approximately 1% of the company's total share capital. This reduction does not include the shares held indirectly by the controlling shareholder and actual controllers Wu Renrong, Gao Zhengsong, and Chen Xinguo in Shuntai Zonghua
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments